Latest On Mustang Bio, Inc (MBIO):
About Mustang Bio, Inc (MBIO):
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develop MB-107, a gene therapy program, potential curative treatment for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. Its ex vivo lentiviral gene therapy is in two Phase 1/2 clinical trials. The company also develops MB-102, a heterodimeric interleukin-3-receptor for acute myeloid leukemia; MB-106 for immunotherapy of B-cell lymphomas; MB-104, an NK cell receptor regulating immune functions; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has a license agreement with Nationwide Children's Hospital for the development of an oncolytic virus for treating GBM; and Beth Israel Deaconess Medical Center, Inc. to perform research relating to gene editing. The company was incorporated in 2015 and is headquartered in New York, New York. Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc.
General
- Name Mustang Bio, Inc
- Symbol MBIO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 51
- Fiscal Year EndDecember
- IPO Date2017-08-22
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.mustangbio.com
Valuation
- Price/Book (Most Recent Quarter) 3.01
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.25
- Return on Assets -38%
- Return on Equity -80%
- Revenue -50000
- Earnings Per Share -$1.33
- Revenue Per Share $-0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 229.58 million
- EBITDA -38426000
- Analyst Target Price $10.75
- Book Value Per Share $1.26
Share Statistics
- Shares Outstanding 64.75 million
- Shares Float 50.5 million
- % Held by Insiders 2242%
- % Held by Institutions 26.32%
- Shares Short 2.69 million
- Shares Short Prior Month 2.99 million
- Short Ratio 0.92
- Short % of Float 5%
- Short % of Shares Outstanding 4%
Technicals
- Beta 1.78
- 52 Week High $5.22
- 52 Week Low $1.97
- 50 Day Moving Average 3.91
- 200 Day Moving Average 3.55
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Mustang Bio, Inc (MBIO) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Mustang Bio, Inc (MBIO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-06 | $N/A | -$0.23 | -$0.24 | 4.17% |
2020-06-30 | 2020-08-10 | $N/A | -$0.32 | -$0.27 | -19.99% |
2020-03-31 | 2020-05-11 | $N/A | -$0.28 | -$0.31 | 8.71% |
2019-12-31 | 2020-03-16 | $N/A | -$0.41 | -$0.26 | -55.72% |
2019-09-30 | 2019-11-12 | $N/A | -$0.25 | -$0.27 | 5.66% |
2019-06-30 | 2019-08-09 | $N/A | -$0.29 | -$0.25 | -16% |
2019-03-31 | 2019-05-10 | $N/A | -$0.34 | -$0.37 | 8.11% |
2018-12-31 | 2019-03-18 | $-50000 | -$0.44 | -$0.27 | -62.96% |
2018-09-30 | 2018-11-13 | $N/A | -$0.28 | -$0.25 | -12% |
2018-06-30 | 2018-08-13 | $-50000 | -$0.19 | -$0.25 | 24% |
2018-03-31 | 2018-05-14 | $50000 | -$0.24 | -$0.23 | -4.35% |
2017-12-31 | 2018-03-29 | $N/A | -$0.61 | -$0.24 | -154.17% |
2017-09-30 | 2017-11-14 | $N/A | -$0.27 |
Mustang Bio, Inc (MBIO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Mustang Bio, Inc (MBIO) Chart:
Mustang Bio, Inc (MBIO) News:
Below you will find a list of latest news for Mustang Bio, Inc (MBIO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Mustang Bio, Inc (MBIO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest MBIO Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:52 PM EST | 100 | $0.586 |
Jun 13, 2022 7:52 PM EST | 400 | $0.5859 |
Jun 13, 2022 7:59 PM EST | 100 | $0.5939 |
Jun 13, 2022 7:59 PM EST | 62 | $0.5925 |
Jun 13, 2022 7:59 PM EST | 38 | $0.5925 |
Mustang Bio, Inc (MBIO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920075268/0001104659-20-075268-index.htm |
2018-07-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1680048/000000000018022168/0000000000-18-022168-index.htm |
2019-08-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1680048/000000000019012766/0000000000-19-012766-index.htm |
2019-08-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1680048/000000000019012768/0000000000-19-012768-index.htm |
2019-09-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1680048/000000000019013323/0000000000-19-013323-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465919062062/0001104659-19-062062-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000110465919062079/0001104659-19-062079-index.htm |
2020-01-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005207/0001104659-20-005207-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005208/0001104659-20-005208-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005209/0001104659-20-005209-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005210/0001104659-20-005210-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005211/0001104659-20-005211-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005212/0001104659-20-005212-index.htm |
2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1680048/000110465920034130/0001104659-20-034130-index.htm |
2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920034139/0001104659-20-034139-index.htm |
2020-04-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052882/0001104659-20-052882-index.htm |
2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052883/0001104659-20-052883-index.htm |
2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052884/0001104659-20-052884-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1680048/000110465920053522/0001104659-20-053522-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1680048/000110465920053524/0001104659-20-053524-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920059618/0001104659-20-059618-index.htm |
2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000110465920059648/0001104659-20-059648-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920065513/0001104659-20-065513-index.htm |
2020-06-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1680048/000110465920069666/0001104659-20-069666-index.htm |
2020-06-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000110465920072000/0001104659-20-072000-index.htm |
2020-06-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000110465920072893/0001104659-20-072893-index.htm |
2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920073151/0001104659-20-073151-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920073411/0001104659-20-073411-index.htm |
2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920075268/0001104659-20-075268-index.htm |
2020-07-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000110465920084869/0001104659-20-084869-index.htm |
2020-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920086524/0001104659-20-086524-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920092788/0001104659-20-092788-index.htm |
2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920096923/0001104659-20-096923-index.htm |
2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920096924/0001104659-20-096924-index.htm |
2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920096925/0001104659-20-096925-index.htm |
2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920096926/0001104659-20-096926-index.htm |
2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000110465920096928/0001104659-20-096928-index.htm |
2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920112229/0001104659-20-112229-index.htm |
2020-10-23 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920117789/0001104659-20-117789-index.htm |
2020-10-23 | PRE 14C | Other preliminary information statements | https://www.sec.gov/Archives/edgar/data/1680048/000110465920117791/0001104659-20-117791-index.htm |
2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000110465920122540/0001104659-20-122540-index.htm |
2020-05-29 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1680048/000114036120012672/0001140361-20-012672-index.htm |
2017-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417021777/0001144204-17-021777-index.htm |
2017-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420417023120/0001144204-17-023120-index.htm |
2017-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420417027453/0001144204-17-027453-index.htm |
2017-05-26 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1680048/000114420417029848/0001144204-17-029848-index.htm |
2017-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031316/0001144204-17-031316-index.htm |
2017-06-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031581/0001144204-17-031581-index.htm |
2017-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm |
2017-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031962/0001144204-17-031962-index.htm |
2017-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417032335/0001144204-17-032335-index.htm |
2017-06-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417035223/0001144204-17-035223-index.htm |
2017-06-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417035224/0001144204-17-035224-index.htm |
2017-06-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417035225/0001144204-17-035225-index.htm |
2017-06-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417035228/0001144204-17-035228-index.htm |
2017-06-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417035231/0001144204-17-035231-index.htm |
2017-07-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417037552/0001144204-17-037552-index.htm |
2017-07-20 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417037554/0001144204-17-037554-index.htm |
2017-07-20 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420417037556/0001144204-17-037556-index.htm |
2017-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420417042638/0001144204-17-042638-index.htm |
2017-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417043220/0001144204-17-043220-index.htm |
2017-08-21 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420417044272/0001144204-17-044272-index.htm |
2017-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417054794/0001144204-17-054794-index.htm |
2017-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420417058627/0001144204-17-058627-index.htm |
2017-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420417058634/0001144204-17-058634-index.htm |
2017-11-14 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420417058649/0001144204-17-058649-index.htm |
2017-11-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1680048/000114420417061594/0001144204-17-061594-index.htm |
2018-03-29 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1680048/000114420418017988/0001144204-18-017988-index.htm |
2018-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418018013/0001144204-18-018013-index.htm |
2018-04-20 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420418021629/0001144204-18-021629-index.htm |
2018-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1680048/000114420418023924/0001144204-18-023924-index.htm |
2018-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420418028256/0001144204-18-028256-index.htm |
2018-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418028322/0001144204-18-028322-index.htm |
2018-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418034421/0001144204-18-034421-index.htm |
2018-07-13 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418038364/0001144204-18-038364-index.htm |
2018-07-20 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418039173/0001144204-18-039173-index.htm |
2018-07-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1680048/000114420418039176/0001144204-18-039176-index.htm |
2018-07-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1680048/000114420418039674/0001144204-18-039674-index.htm |
2018-07-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420418040507/0001144204-18-040507-index.htm |
2018-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418040510/0001144204-18-040510-index.htm |
2018-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420418044004/0001144204-18-044004-index.htm |
2018-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418044019/0001144204-18-044019-index.htm |
2018-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418057391/0001144204-18-057391-index.htm |
2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418058924/0001144204-18-058924-index.htm |
2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420418059357/0001144204-18-059357-index.htm |
2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420418059460/0001144204-18-059460-index.htm |
2018-11-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418061731/0001144204-18-061731-index.htm |
2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418062799/0001144204-18-062799-index.htm |
2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418063619/0001144204-18-063619-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1680048/000114420419014624/0001144204-19-014624-index.htm |
2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419014633/0001144204-19-014633-index.htm |
2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419018182/0001144204-19-018182-index.htm |
2019-04-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420419021930/0001144204-19-021930-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420419022360/0001144204-19-022360-index.htm |
2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1680048/000114420419022371/0001144204-19-022371-index.htm |
2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419022388/0001144204-19-022388-index.htm |
2019-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420419022960/0001144204-19-022960-index.htm |
2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420419025065/0001144204-19-025065-index.htm |
2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419025070/0001144204-19-025070-index.htm |
2019-05-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1680048/000114420419027112/0001144204-19-027112-index.htm |
2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419031510/0001144204-19-031510-index.htm |
2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000114420419038877/0001144204-19-038877-index.htm |
2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419038913/0001144204-19-038913-index.htm |
2019-08-16 | PRE 14C | Other preliminary information statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420419040428/0001144204-19-040428-index.htm |
2019-08-16 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1680048/000114420419040430/0001144204-19-040430-index.htm |
2019-08-30 | PRER14C | Information statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420419043050/0001144204-19-043050-index.htm |
2019-08-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1680048/000114420419043052/0001144204-19-043052-index.htm |
2019-09-10 | DEF 14C | Other definitive information statements | https://www.sec.gov/Archives/edgar/data/1680048/000114420419044167/0001144204-19-044167-index.htm |
2019-09-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1680048/000114420419046071/0001144204-19-046071-index.htm |
2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1680048/000114420419046520/0001144204-19-046520-index.htm |
2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000155837020010205/0001558370-20-010205-index.htm |
2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1680048/000155837020013156/0001558370-20-013156-index.htm |
2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1680048/000157104918000270/0001571049-18-000270-index.htm |
2017-04-12 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1680048/000168004817000004/0001680048-17-000004-index.htm |
2018-07-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1680048/999999999518001921/9999999995-18-001921-index.htm |
2019-09-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1680048/999999999519002209/9999999995-19-002209-index.htm |
2017-08-21 | CERTNAS | Certification by the Nasdaq Stock Market approving securities for listing | https://www.sec.gov/Archives/edgar/data/1680048/999999999717008165/9999999997-17-008165-index.htm |
2017-09-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1680048/999999999717008908/9999999997-17-008908-index.htm |
2017-11-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1680048/999999999717009967/9999999997-17-009967-index.htm |
Mustang Bio, Inc (MBIO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mustang Bio, Inc (MBIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2242%Institutional Ownership: 2632%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2017-03-13 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 767,264.00 | 10,131,053.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2017-03-31 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 1,600.00 | 10,132,653.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2018-11-26 | Manuel MD Litchman | President and CEO | Buy | 5,000.00 | 3.87 | 19,353.50 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2020-03-26 | Brian Achenbach | SVP, Fin. & Corp. Controller | Buy | 36,250.00 | 129,274.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052883/0001104659-20-052883-index.htm | ||
2020-03-26 | Manuel MD Litchman | President and CEO | Buy | 122,000.00 | 155,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052884/0001104659-20-052884-index.htm | ||
2018-12-04 | Manuel MD Litchman | President and CEO | Buy | 7,500.00 | 3.60 | 27,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2018-06-14 | MICHAEL S WEISS | Director | Buy | 10,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005209/0001104659-20-005209-index.htm | ||
2020-05-14 | Manuel MD Litchman | President and CEO | Buy | 90,000.00 | 2.79 | 251,100.00 | 245,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920065513/0001104659-20-065513-index.htm |
2018-11-20 | Manuel MD Litchman | President and CEO | Buy | 2,500.00 | 3.89 | 9,720.25 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2018-12-10 | Manuel MD Litchman | President and CEO | Buy | 8,000.00 | 3.35 | 26,804.80 | 28,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2020-03-05 | Manuel MD Litchman | President and CEO | Buy | 5,000.00 | 2.48 | 12,400.00 | 33,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052884/0001104659-20-052884-index.htm |
2020-05-21 | Manuel MD Litchman | President and CEO | Buy | 90,000.00 | 3.13 | 281,700.00 | 335,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920065513/0001104659-20-065513-index.htm |
2019-08-28 | MICHAEL S WEISS | Director | Buy | 13,812.00 | 33,812.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005209/0001104659-20-005209-index.htm | ||
2020-06-11 | Manuel MD Litchman | President and CEO | Buy | 153,846.00 | 3.25 | 499,999.50 | 488,846.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920073411/0001104659-20-073411-index.htm |
2018-02-02 | Brian Achenbach | VP, Fin. & Corp. Controller | Buy | 55,000.00 | 55,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418062799/0001144204-18-062799-index.htm | ||
2018-11-16 | Brian Achenbach | VP, Fin. & Corp. Controller | Buy | 1,000.00 | 4.31 | 4,310.00 | 56,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418062799/0001144204-18-062799-index.htm |
2018-11-19 | Brian Achenbach | VP, Fin. & Corp. Controller | Buy | 1,000.00 | 4.25 | 4,250.00 | 57,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418062799/0001144204-18-062799-index.htm |
2018-11-20 | Brian Achenbach | VP, Fin. & Corp. Controller | Buy | 500.00 | 3.87 | 1,937.10 | 57,500.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418062799/0001144204-18-062799-index.htm |
2018-06-14 | Adam J. Chill | Director | Buy | 10,000.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418058924/0001144204-18-058924-index.htm | ||
2018-11-08 | Adam J. Chill | Director | Buy | 2,000.00 | 5.34 | 10,680.00 | 62,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418058924/0001144204-18-058924-index.htm |
2018-11-12 | Adam J. Chill | Director | Buy | 1,000.00 | 4.85 | 4,850.00 | 63,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418058924/0001144204-18-058924-index.htm |
2018-11-02 | LINDSAY A MD ROSENWALD | Director | Buy | 50,000.00 | 4.41 | 220,500.00 | 70,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418057391/0001144204-18-057391-index.htm |
2018-06-14 | Neil Herskowitz | Director | Buy | 10,000.00 | 70,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418063619/0001144204-18-063619-index.htm | ||
2018-11-23 | Neil Herskowitz | Director | Buy | 1,000.00 | 3.96 | 3,960.00 | 71,000.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418063619/0001144204-18-063619-index.htm |
2018-11-21 | Manuel MD Litchman | President and CEO | Buy | 5,000.00 | 4.21 | 21,048.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/0001144204-18-065170-index.htm |
2019-08-28 | Adam J. Chill | Director | Buy | 13,812.00 | 76,812.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005210/0001104659-20-005210-index.htm | ||
2019-08-28 | LINDSAY A MD ROSENWALD | Director | Buy | 13,812.00 | 83,812.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005208/0001104659-20-005208-index.htm | ||
2019-08-28 | Neil Herskowitz | Director | Buy | 13,812.00 | 84,812.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005211/0001104659-20-005211-index.htm | ||
2016-09-30 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 47,870.00 | 9,047,870.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2016-10-25 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 27,264.00 | 9,075,134.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2016-11-30 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 47,505.00 | 9,122,639.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2016-12-12 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 11,925.00 | 9,134,564.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2016-12-29 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 15,806.00 | 9,150,370.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm | ||
2019-04-16 | Brian Achenbach | SVP, Fin. & Corp. Controller | Buy | 35,000.00 | 92,500.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920005212/0001104659-20-005212-index.htm | ||
2020-03-05 | Brian Achenbach | SVP, Fin. & Corp. Controller | Buy | 524.00 | 2.48 | 1,299.52 | 93,024.00 | https://www.sec.gov/Archives/edgar/data/1680048/000110465920052883/0001104659-20-052883-index.htm |
2017-01-31 | Fortress Biotech, Inc. | 10% Share Holder | Buy | 213,419.00 | 9,363,789.00 | https://www.sec.gov/Archives/edgar/data/1680048/000114420417031582/0001144204-17-031582-index.htm |